TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 1 | 1 | 1 | 0 | 20 | -4 | -28 | -50 | -38 | -20 |
P | %wins | 100 | 100 | 0 | 0 | 0 | 0 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/30/24 19:00 | 1/26/24 | RNXT | Renovorx, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Spiegel Robert J. | CA | D | P.d | 0 | 0.00 | 0 | 41 | New | 41 | D | |||||||||||||||
8/30/22 18:41 | 8/3/22 | ATNX | Athenex, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Spiegel Robert J. | NY | D | M.d | 0 | 0.00 | 0 | 9 | 103 | 17 | D | |||||||||||||||
3/18/19 17:57 | 3/15/19 | EDGE | Edge Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Spiegel Robert J. | NJ | D | M.d | 0 | 0.00 | 0 | 10 | 26 | 49 | D | |||||||||||||||
9/13/18 21:28 | 9/13/18 | GERN | Geron Corp | DE | Health | Drug | Pharmaceutical Preparations | Spiegel Robert J. | CA | D | M.d | 517 | 2.95 | 0 | 175 | 66 | D | ||||||||||||||||
9/13/18 21:28 | 9/13/18 | GERN | Geron Corp | DE | Health | Drug | Pharmaceutical Preparations | Spiegel Robert J. | CA | D | S.d | -1,199 | 6.85 | 0 | -175 | -73 | 66 | D | |||||||||||||||
10/8/15 16:14 | 10/6/15 | EDGE | Edge Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Spiegel Robert J. | NJ | D | P.d | 33 | 11.00 | 7 | 3 | 8 | 39 | D | 2 | 0 | 20 | -4 | -28 | -50 | -38 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |